1.78BMarket Cap
LossP/E TTM
BCAX Financials
See Bicara Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Bicara Therapeutics Inc Earnings Date
Latest Release
May 11, 2026
EPS / Forecast
-0.93/-0.75
Revenue / Forecast
--/0.00
Analyst Rating
BUY
2026/08/02
FAQs
What are the current assets of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its current assets were 422.05M, with a year-on-year change of -16.01.
What are the total assets of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its total assets of Bicara Therapeutics Inc were 430.99M, with a year-on-year change of -15.49.
What are the total liabilities of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its total liabilities of Bicara Therapeutics Inc were 29.54M, with a year-on-year change of 63.03.
What is the total equity of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its total equity of Bicara Therapeutics Inc was 401.45M, with a year-on-year change of -18.38.
What is the net operating income of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its net operating income of Bicara Therapeutics Inc was -155.60M, with a year-on-year change of -88.87.
What is the net investment of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its net investment of Bicara Therapeutics Inc was -318.45M, with a year-on-year change of -3538266.67.
What is the net financing of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its net financing of Bicara Therapeutics Inc was 32.26M, with a year-on-year change of -90.34.
What is the Earnings Per Share (EPS) of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.52, with a year-on-year change of 37.64.
What is the net income of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its net income was -137.95M, with a year-on-year change of -102.88.
What is the Return on Equity (ROE) of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -30.88, with a year-on-year change of 22.08.
What is the Return on Assets (ROA) of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -29.32, with a year-on-year change of -60.41.
What is the operating profit of Bicara Therapeutics Inc?
According to Bicara Therapeutics Inc's FY2025 earnings report, its operating profit was -155.60M, with a year-on-year change of -88.87.